1. In-silico study unveils potential phytocompounds in Andrographis paniculata against E6 protein of the high-risk HPV-16 subtype for cervical cancer therapy.
- Author
-
Islam MA, Hossain MS, Hasnat S, Shuvo MH, Akter S, Maria MA, Tahcin A, Hossain MA, and Hoque MN
- Subjects
- Humans, Female, Repressor Proteins metabolism, Repressor Proteins antagonists & inhibitors, Repressor Proteins chemistry, Phytochemicals pharmacology, Phytochemicals chemistry, Computer Simulation, Plant Extracts chemistry, Plant Extracts pharmacology, Molecular Dynamics Simulation, Papillomavirus Infections drug therapy, Papillomavirus Infections virology, Diterpenes pharmacology, Diterpenes chemistry, Protein Binding, Uterine Cervical Neoplasms drug therapy, Uterine Cervical Neoplasms virology, Molecular Docking Simulation, Oncogene Proteins, Viral metabolism, Oncogene Proteins, Viral chemistry, Andrographis chemistry, Human papillomavirus 16 drug effects
- Abstract
Despite therapeutic advancements, cervical cancer caused by high-risk subtypes of the human papillomavirus (HPV) remains a leading cause of cancer-related deaths among women worldwide. This study aimed to discover potential drug candidates from the Asian medicinal plant Andrographis paniculata, demonstrating efficacy against the E6 protein of high-risk HPV-16 subtype through an in-silico computational approach. The 3D structures of 32 compounds (selected from 42) derived from A. paniculata, exhibiting higher binding affinity, were obtained from the PubChem database. These structures underwent subsequent analysis and screening based on criteria including binding energy, molecular docking, drug likeness and toxicity prediction using computational techniques. Considering the spectrometry, pharmacokinetic properties, docking results, drug likeliness, and toxicological effects, five compounds-stigmasterol, 1H-Indole-3-carboxylic acid, 5-methoxy-, methyl ester (AP7), andrographolide, apigenin and wogonin-were selected as the potential inhibitors against the E6 protein of HPV-16. We also performed 200 ns molecular dynamics simulations of the compounds to analyze their stability and interactions as protein-ligand complexes using imiquimod (CID-57469) as a control. Screened compounds showed favorable characteristics, including stable root mean square deviation values, minimal root mean square fluctuations and consistent radius of gyration values. Intermolecular interactions, such as hydrogen bonds and hydrophobic contacts, were sustained throughout the simulations. The compounds displayed potential affinity, as indicated by negative binding free energy values. Overall, findings of this study suggest that the selected compounds have the potential to act as inhibitors against the E6 protein of HPV-16, offering promising prospects for the treatment and management of CC., (© 2024. The Author(s).)
- Published
- 2024
- Full Text
- View/download PDF